Averaging up to 20% of weight loss, adults taking Zepbound had at least 25 fewer breathing interruptions each hour as they slept Up to 50% of adults taking Zepbound no longer had symptoms associated with OSA after one year INDIANAPOLIS, Dec. 20, 2024 /PRNewswire/ -- Eli Lilly and Company...
Read More Details
Finally We wish PressBee provided you with enough information of ( FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity )
Also on site :
- Tears and Shock: First Islander Sent Home on ‘Love Island USA’ Season 7
- A Gaza-bound aid boat carrying Greta Thunberg and other activists has been diverted to Israel
- 'Hamilton’ Original Cast Reunites at 2025 Tony Awards & Fans Are Saying the Same Thing